跳至主要内容
临床试验/NL-OMON44655
NL-OMON44655已完成不适用

MRI for radiotherapy treatment planning of stage III NSCLC: an MRI optimization study in healthy volunteers and patients - MRI optimization study in stage III NSCLC

niversitair Medisch Centrum Utrecht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy volunteers
  • - *18 years
  • - written informed consent;Patients:
  • - patients with histopathologically or cytologically proven stage III NSCLC (excluding T4N0) referred to the department of Radiation Oncology
  • - * 18 years
  • - written informed consent
  • - recent (* 3 months) GFR value available

排除标准

  • Healthy volunteers:
  • - volunteers who meet exclusion criteria for MRI following the protocol of the department of Radiology of the UMC Utrecht;Patients:
  • - patients who meet exclusion criteria for MRI following the protocol of the department of Radiology of the UMC Utrecht
  • - patients for whom lying still in a supine position for 45 minutes is physically too strenuous (e.g. due to orthopnea)
  • - Glomerular Filtration Rate (GFR) of <30 mL/min/1.73m2 (UMCU protocol *MRI Contra-indicaties*, Version 3 January 2013)
  • - patients with nephrogenic systemic fibrosis, nephrogenic fibrosing dermopathy or severe renal insufficiency (UMCU protocol *MRI Contra-indicaties*, Version 3 January 2013)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验